<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Healthcare</title>
	<atom:link href="http://pharmaexecnews.com/category/medical/healthcare-medical/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Antibiotics – A Possible Cure for Anthrax?</title>
		<link>http://pharmaexecnews.com/biotechnology/antibiotics-cure-anthrax/</link>
		<comments>http://pharmaexecnews.com/biotechnology/antibiotics-cure-anthrax/#comments</comments>
		<pubDate>Wed, 27 Apr 2011 14:00:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Healthcare]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11522</guid>
		<description><![CDATA[Anthrax is an acute disease caused by the bacterium Bacillus anthracis. Most forms of the disease are lethal, and it affects both humans and other animals. There are effective vaccines against anthrax, and some forms of the disease respond well to antibiotic treatment.

In the absence of early antibiotic treatment, the respiratory form of anthrax can [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/antibiotics-cure-anthrax/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Researchers Gain More Insight on How Thalidomide Leads to Birth Defects</title>
		<link>http://pharmaexecnews.com/biotechnology/researchers-gain-insight-thalidomide-leads-birth-defects/</link>
		<comments>http://pharmaexecnews.com/biotechnology/researchers-gain-insight-thalidomide-leads-birth-defects/#comments</comments>
		<pubDate>Wed, 27 Apr 2011 08:00:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11518</guid>
		<description><![CDATA[Thalidomide was introduced as a sedative drug in the late 1950s. In 1961, it was withdrawn due to teratogenicity and neuropathy. There is now a growing clinical interest in thalidomide, and it is introduced as an immunomodulatory agent used primarily, combined with dexamethasone, to treat multiple myeloma. The drug is a potent teratogen in zebrafish, [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/researchers-gain-insight-thalidomide-leads-birth-defects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Low Sunlight Exposure and Common Virus Responsible for Multiple Sclerosis</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/#comments</comments>
		<pubDate>Tue, 26 Apr 2011 14:00:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11514</guid>
		<description><![CDATA[New research has indicated that people who are exposed to very low levels of sunlight and who also have a history of having a common virus known as mononucleosis, are at greater odds of developing multiple sclerosis (MS) than those without the virus.

According to George C. Ebers, MD, with the University of Oxford in the [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Preventing Damage from Heart Attacks &amp; Strokes with an Injection</title>
		<link>http://pharmaexecnews.com/biotechnology/preventing-damage-heart-attacks-strokes-injection/</link>
		<comments>http://pharmaexecnews.com/biotechnology/preventing-damage-heart-attacks-strokes-injection/#comments</comments>
		<pubDate>Tue, 26 Apr 2011 08:00:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[New Drugs]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11510</guid>
		<description><![CDATA[A researching team from the University of Leicester has offered the promise of a simple injection that could be developed to restrict the damage that results from heart attacks and strokes. Described by the lead researcher as &#8216;a fascinating new achievement&#8217;, work has already begun to translate the research into novel clinical therapies.

Professor Wilhelm Schwaeble [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/preventing-damage-heart-attacks-strokes-injection/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Using Nanoparticles to Kill Cancer Cells</title>
		<link>http://pharmaexecnews.com/biotechnology/nanoparticles-kill-cancer-cells/</link>
		<comments>http://pharmaexecnews.com/biotechnology/nanoparticles-kill-cancer-cells/#comments</comments>
		<pubDate>Mon, 25 Apr 2011 08:00:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Oncology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11503</guid>
		<description><![CDATA[By combining nanotechnology and medical research, Sandia National Laboratories, the University of New Mexico, and the UNM Cancer Research and Treatment Center, have successfully been able to produce a highly efficient strategy that makes use of nanoparticles to kill cancerous cells with a wide variety of drugs.

The researchers describe their study using silica nanoparticles about [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/nanoparticles-kill-cancer-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Coffee Addiction Linked to Genetics</title>
		<link>http://pharmaexecnews.com/biotechnology/genomics/coffee-addiction-linked-genetics/</link>
		<comments>http://pharmaexecnews.com/biotechnology/genomics/coffee-addiction-linked-genetics/#comments</comments>
		<pubDate>Fri, 22 Apr 2011 08:00:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Healthcare]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11493</guid>
		<description><![CDATA[If you thought that you are a person who craves coffee more than others, then now is the time to explore your genetics, as scientist have proven that caffeine addiction is part of our DNA.  According to a report, there are differences in two genes which cause people to consume more or less caffeine. Individuals [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/genomics/coffee-addiction-linked-genetics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nasal Spray Vaccines More Effective against Flu</title>
		<link>http://pharmaexecnews.com/biotechnology/nasal-spray-vaccines-effective-flu/</link>
		<comments>http://pharmaexecnews.com/biotechnology/nasal-spray-vaccines-effective-flu/#comments</comments>
		<pubDate>Thu, 21 Apr 2011 08:00:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Vaccines]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11485</guid>
		<description><![CDATA[New research has shown that nasal vaccines are much more effective in providing protection against the flu. In fact the research also proved that nasal vaccines will soon protect not only against the flu and pneumonia, but also against bioterrorism agents such as Yersinia pestis that causes the plague. The research, presented at the Society [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/nasal-spray-vaccines-effective-flu/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Causes of Sudden Infant Death Syndrome Likely in the Brain</title>
		<link>http://pharmaexecnews.com/medical/healthcare-medical/sudden-infant-death-syndrome-brain/</link>
		<comments>http://pharmaexecnews.com/medical/healthcare-medical/sudden-infant-death-syndrome-brain/#comments</comments>
		<pubDate>Fri, 15 Apr 2011 08:00:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11449</guid>
		<description><![CDATA[Recent research has shown that the cause of Sudden Infant Death Syndrome (SIDS) is likely to be in the brain. SIDS is yet to be understood by scientists properly and the condition is also known as ‘cot death’.  The new research conducted by the Macquarie University in Sydney looks at particular regions of the brain [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/medical/healthcare-medical/sudden-infant-death-syndrome-brain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Arthritis Drug to Combat Melanoma Skin Cancer</title>
		<link>http://pharmaexecnews.com/medical/healthcare-medical/arthritis-drug-combat-melanoma-skin-cancer/</link>
		<comments>http://pharmaexecnews.com/medical/healthcare-medical/arthritis-drug-combat-melanoma-skin-cancer/#comments</comments>
		<pubDate>Fri, 01 Apr 2011 14:00:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Disease]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[R&D]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11406</guid>
		<description><![CDATA[In what could be the biggest breakthrough in the treatment of one of the deadliest cancer types, researchers at the University of East Anglia (UEA) and Children&#8217;s Hospital Boston have unveiled an effective new treatment for treating melanoma skin cancer.

The researchers have discovered that leflunomide &#8211; a medicine generally used to treat rheumatoid arthritis – [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/medical/healthcare-medical/arthritis-drug-combat-melanoma-skin-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Research to Help in Treating Fatal Blood Clots</title>
		<link>http://pharmaexecnews.com/biotechnology/research-treating-fatal-blood-clots/</link>
		<comments>http://pharmaexecnews.com/biotechnology/research-treating-fatal-blood-clots/#comments</comments>
		<pubDate>Fri, 01 Apr 2011 08:00:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11403</guid>
		<description><![CDATA[New scientific research published by the American Heart Association has indicated that doctors are motivated to turn towards therapeutic treatments along with blood thinners to relieve patients suffering from fatal blood clots found in deep veins that ultimately travel to the lungs.

Every year, over 250,000 people in the United States fall victim to deep vein [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/research-treating-fatal-blood-clots/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

